Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Embolization of sacral tumors.

Oren N Gottfried1, Meic H Schmidt, Edwin A Stevens

  • 1Department of Neurosurgery, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA. Oren.Gottfried@hsc.utah.edu

Neurosurgical Focus
|September 8, 2004
PubMed
Summary

Embolization offers a valuable treatment option for challenging sacral tumors, improving symptoms and aiding surgical resection. This interventional radiology technique should be considered for both benign and malignant sacral lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing those Most Satisfied Versus Least Satisfied Following Surgery for Cervical Spondylotic Myelopathy: Are there Differences in Baseline Characteristics?

Spine·2026
Same author

Predictors of long-term myelopathy relief in patients with moderate to severe cervical spondylotic myelopathy following surgery: a Spine CORe™ analysis of QOD data.

Neurosurgical focus·2026
Same author

What determines patient satisfaction after surgery for grade 2 lumbar spondylolisthesis? A Spine CORe™ analysis of QOD data.

Neurosurgical focus·2026
Same author

Is patient satisfaction static at 5 years after surgery for cervical spondylotic myelopathy? A Spine CORe™ analysis of QOD data.

Neurosurgical focus·2026
Same author

What is the average time frame of clinically meaningful improvement in surgical decompression for cervical spondylotic myelopathy? A Spine CORe™ analysis of QOD data: 5-year follow-up.

Neurosurgical focus·2026
Same author

What are the predictors of prolonged length of stay following single-stage lumbar fusion for grade 2 spondylolisthesis? A Spine CORe™ analysis of QOD data.

Neurosurgical focus·2026

Area of Science:

  • Interventional Radiology
  • Oncology
  • Neurosurgery

Background:

  • Sacral tumors present significant management challenges due to difficult access, high recurrence rates, vascularity, and potential for malignant transformation.
  • While surgery is primary, limitations necessitate exploring alternative and adjunctive therapies for sacral tumors.

Purpose of the Study:

  • To evaluate the role of embolization as a primary and adjunctive therapy in managing sacral tumors.
  • To highlight the benefits of embolization in improving patient outcomes and facilitating surgical interventions.

Main Methods:

  • Review of embolization techniques used in the treatment of various sacral tumors.
  • Analysis of patient responses to embolization for benign, malignant, and metastatic lesions.

Related Experiment Videos

Main Results:

  • Embolization demonstrated efficacy in resolving symptoms and promoting ossification in benign lesions like aneurysmal bone cysts and giant cell tumors.
  • For metastatic sacral lesions, embolization led to neurological improvement, tumor size reduction, and decreased spinal canal compromise.
  • Embolization effectively reduced intraoperative blood loss and facilitated the resection of diverse sacral tumor types.

Conclusions:

  • Embolization techniques represent a valuable resource in the comprehensive management of sacral tumors.
  • Embolization should be consistently considered as a therapeutic option for patients diagnosed with sacral tumors, offering both primary and adjuvant benefits.